Get More Information on Smart Inhalers Market - Request Sample Report
The Smart Inhalers Market size amounted to USD 15.77 Billion In 2023 & is estimated to reach USD 78.36 Billion by 2032 and increase at a compound annual growth rate of 19.5% between 2024 and 2032.
A smart inhaler refers to a type of medical device designed to help individuals with respiratory conditions, such as asthma or chronic obstructive pulmonary disease (COPD), manage their inhaler medication more effectively. These devices are equipped with technology that allows them to track and record inhaler usage, providing patients and healthcare providers with valuable data to monitor and improve treatment outcomes. Dose Tracking is the device that records the date and time of each inhaler dose, helping patients keep track of their medication regimen. Medication Reminders Some smart inhalers send reminders to patients' smartphones or other devices to ensure they take their medication as prescribed. Usage Monitoring: These inhalers can detect and notify patients if they are not using their inhalers correctly, helping to ensure proper technique.
Data Sharing is the Smart inhalers may have the capability to share usage data with healthcare providers, allowing them to monitor patients' adherence to treatment plans and make adjustments if needed. Health Insights is the data collected by smart inhalers that can provide insights into patients' asthma or COPD management, potentially leading to improved disease control. The smart inhaler market has been growing due to the increasing prevalence of respiratory conditions, the emphasis on remote patient monitoring, and the integration of technology into healthcare. However, specific market trends, companies, and advancements in this field may have evolved since then. To get the most up-to-date and accurate information about the current state of the Smart Inhalers Market.
Smart inhalers are devices that are used to administer a range of medications by inhalation. Inhalers contain anti-cholinergic, glucocorticoids, insulin, and beta-agonists, which are used to treat and prevent respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). These inhalers are called smart inhalers simply because they're sensors connected together as a clip for an inhaler, which monitors the correct dosage per dose and method of inhalation. The sensor's data is shared with the patient and healthcare experts in order to follow their inhaler usage. The data collected is then communicated via Bluetooth technology to their mobile applications via an internet platform, and electronic health records (EHR) or electronic medical records (EMR) are kept. Some smart inhalers have sensors that can identify whether a person is in a polluted or pollen-filled environment, offer useful reminders, and signal whether an inhaler technique needs to be checked. Individuals do not need to keep their own records because they are all intended to automatically track how frequently an inhaler is used. Furthermore, an increase in the population living in underdeveloped and emerging nations makes them vulnerable to indoor air pollution. People who live in poor housing and neighbourhood circumstances are more sensitive to respiratory diseases like COPD and asthma.
DRIVERS:
The prevalence of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) continues to increase globally.
Technological Advancements are the driver of the Smart Inhalers Market.
Advances in sensor technology, wireless communication, and miniaturization have made it possible to develop smart inhalers that can accurately track inhaler usage and provide real-time data.
RESTRAIN:
Smart inhalers can be more expensive than traditional inhalers, which might limit their adoption.
Privacy and Data Security is the restrain of the Smart Inhalers Market.
The collection and transmission of patient data raise concerns about privacy and data security. Patients and healthcare providers need assurance that sensitive health information is protected from unauthorized access or breaches.
OPPORTUNITY:
Smart inhalers have the potential to significantly improve patient outcomes by enhancing medication adherence.
Personalized Treatment is an opportunity in the Smart Inhalers Market.
The data collected by smart inhalers can enable healthcare providers to tailor treatment plans to individual patients, optimizing medication dosages and inhaler techniques for better efficacy.
CHALLENGES:
Smart inhalers, like any medical device, need to undergo rigorous regulatory approval processes in different regions.
Patient Engagement and Adherence are the challenges of the Smart Inhalers Market.
While smart inhalers can improve adherence through reminders and feedback, some patients might still struggle with consistently using the device as directed.
IMPACT OF RUSSIA-UKRAINE WAR
Europe is in a precarious condition because many nations were directly and indirectly involved in the conflict. War has direct effects on global trade as a result of the international situation. Exports and imports are being impacted, and the current supply situation is deteriorating. Pharmaceutical items are one of the most important Asian exports to Ukraine. Asia is, in reality, Ukraine's third-largest pharmaceutical exporter. Promotion of Pharmaceutical Exports Asia sold over $202 million in pharmaceutical items to Ukraine in FY21, representing a roughly 48 per cent increase over the previous year, while Russia contributed about $610 million last fiscal year, representing a 7.12% increase over the previous year. The brunt of the damage is borne by pharmaceutical companies. A significant export market for pharmaceutical products in Russia and Ukraine. Some Asian pharmaceutical businesses have a considerable presence in those markets. The smart inhaler market suffered a loss of 2.8 to 3.95% profit share during the same period as Russia's Ukraine conflict.
IMPACT OF ONGOING RECESSION
Recession, defined as two consecutive quarters of negative GDP growth, can have a negative impact on population health because economic downturns are strongly associated with a decrease in healthcare utilisation and deterioration in health outcomes. During the current recession, the number of uninsured non-elderly Americans grew by 8.2 million between 2020 and 2022, and more than a quarter of Americans reported a reduction in routine medical care utilisation. At the same time, insurance premiums and copayments for doctor visits and prescription medicines have increased over this period, resulting in a higher financial burden on individuals. The smart inhaler market is increasing its product prices by 3.15-3.36% and its share of grain profits by 4-5 % in the ongoing recession.
By Product
Nebulizers
Inhalers
By Indication
COPD
Asthma
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
North America: North America's market size was the United States, and it is expected to develop rapidly due to factors such as increased digitization in the healthcare industry, positive government policies, and flexible regulatory settings. Furthermore, increased private and governmental investment in smart inhalers will drive regional growth throughout the predicted period. As a result, such elements are to blame for the market's good expansion in North America.
Asia Pacific: The Asia Pacific market is expected to develop at a rapid pace, owing to a rising number of suppliers entering the untapped emerging Asian nations. Furthermore, increased investment in healthcare IT development in emerging markets will fuel regional growth.
Get Customized Report as per Your Business Requirement - Request For Customized Report
Key Players
Some major players in Smart Inhalers Market are Adherium Limited, Pneuma Respiratory Inc., H&T Presspart Manufacturing Ltd., COHERO Health Inc., Personal Air Quality Systems Private Limited, Cognita Labs, Teva Pharmaceuticals Industries Ltd., Amiko Digital Health Limited, Novartis AG, Propeller Health and other players.
RECENT DEVELOPMENTS
In 2021: Propeller Health worked with Novartis to integrate the digital health platform with the Enerzair and Atectura Breezhaler drugs, which will be distributed in Japan to treat uncontrolled asthma. The company's digital health sensor will assist consumers in Japan in managing their health conditions using the Propeller app on their smartphones.
In 2020: AptarGroup, Inc. and Sonmol, a Chinese digital respiratory treatments startup, cooperated to create a digital therapies and services platform for respiratory and other disorders. This partnership will assist to focus on early diagnosis and preventive methods for chronic respiratory disorders, which will strengthen the argument for smart inhalers and connected devices as platforms for improving patient health.
| Report Attributes | Details |
| Market Size in 2023 | US$ 15.77 Bn |
| Market Size by 2032 | US$ 78.36 Bn |
| CAGR | CAGR of 19.5 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Nebulizers and Inhalers) • By Indication (COPD and Asthma) • By Distribution Channel (Retail Pharmacies and Hospital Pharmacies) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Adherium Limited, Pneuma Respiratory Inc., H&T Presspart Manufacturing Ltd., COHERO Health Inc., Personal Air Quality Systems Private Limited, Cognita Labs, Teva Pharmaceuticals Industries Ltd., Amiko Digital Health Limited, Novartis AG, Propeller Health |
| Key Drivers | • The prevalence of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) continues to increase globally. • Technological Advancements are the driver of the Smart Inhalers Market. |
| Market Restraints | • Smart inhalers can be more expensive than traditional inhalers, which might limit their adoption. • Privacy and Data Security is the restrain of the Smart Inhalers Market. |
Ans. The Compound Annual Growth rate for Smart Inhalers Market over the forecast period is 19.5%.
Ans. USD 78.36 billion is the projected Smart Inhalers market size by 2032.
Ans. Adherium is the leading player in the global smart inhaler market.
Ans. During the projection period, the Metered Dose Inhaler (MDI)-based inhalers segment is likely to be the market leader.
Ans. These inhalers' superior procedural outcomes are anticipated to boost the use of smart inhaler solutions.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Smart Inhalers Market Segmentation, By Product
8.1 Nebulizers
8.2 Inhalers
9. Smart Inhalers Market Segmentation, By Indication
9.1 COPD
9.2 Asthma
10. Smart Inhalers Market Segmentation, By Distribution Channel
10.1 Retail Pharmacies
10.2 Hospital Pharmacies
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Smart Inhalers Market by Country
11.2.2 North America Smart Inhalers Market by Product
11.2.3 North America Smart Inhalers Market by Indication
11.2.4 North America Smart Inhalers Market by Distribution Channel
11.2.5 USA
11.2.5.1 USA Smart Inhalers Market by Product
11.2.5.2 USA Smart Inhalers Market by Indication
11.2.5.3 USA Smart Inhalers Market by Distribution Channel
11.2.6 Canada
11.2.6.1 Canada Smart Inhalers Market by Product
11.2.6.2 Canada Smart Inhalers Market by Indication
11.2.6.3 Canada Smart Inhalers Market by Distribution Channel
11.2.7 Mexico
11.2.7.1 Mexico Smart Inhalers Market by Product
11.2.7.2 Mexico Smart Inhalers Market by Indication
11.2.7.3 Mexico Smart Inhalers Market by Distribution Channel
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Smart Inhalers Market by Country
11.3.1.2 Eastern Europe Smart Inhalers Market by Product
11.3.1.3 Eastern Europe Smart Inhalers Market by Indication
11.3.1.4 Eastern Europe Smart Inhalers Market by Distribution Channel
11.3.1.5 Poland
11.3.1.5.1 Poland Smart Inhalers Market by Product
11.3.1.5.2 Poland Smart Inhalers Market by Indication
11.3.1.5.3 Poland Smart Inhalers Market by Distribution Channel
11.3.1.6 Romania
11.3.1.6.1 Romania Smart Inhalers Market by Product
11.3.1.6.2 Romania Smart Inhalers Market by Indication
11.3.1.6.4 Romania Smart Inhalers Market by Distribution Channel
11.3.1.7 Turkey
11.3.1.7.1 Turkey Smart Inhalers Market by Product
11.3.1.7.2 Turkey Smart Inhalers Market by Indication
11.3.1.7.3 Turkey Smart Inhalers Market by Distribution Channel
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Smart Inhalers Market by Product
11.3.1.8.2 Rest of Eastern Europe Smart Inhalers Market by Indication
11.3.1.8.3 Rest of Eastern Europe Smart Inhalers Market by Distribution Channel
11.3.2 Western Europe
11.3.2.1 Western Europe Smart Inhalers Market by Country
11.3.2.2 Western Europe Smart Inhalers Market by Product
11.3.2.3 Western Europe Smart Inhalers Market by Indication
11.3.2.4 Western Europe Smart Inhalers Market by Distribution Channel
11.3.2.5 Germany
11.3.2.5.1 Germany Smart Inhalers Market by Product
11.3.2.5.2 Germany Smart Inhalers Market by Indication
11.3.2.5.3 Germany Smart Inhalers Market by Distribution Channel
11.3.2.6 France
11.3.2.6.1 France Smart Inhalers Market by Product
11.3.2.6.2 France Smart Inhalers Market by Indication
11.3.2.6.3 France Smart Inhalers Market by Distribution Channel
11.3.2.7 UK
11.3.2.7.1 UK Smart Inhalers Market by Product
11.3.2.7.2 UK Smart Inhalers Market by Indication
11.3.2.7.3 UK Smart Inhalers Market by Distribution Channel
11.3.2.8 Italy
11.3.2.8.1 Italy Smart Inhalers Market by Product
11.3.2.8.2 Italy Smart Inhalers Market by Indication
11.3.2.8.3 Italy Smart Inhalers Market by Distribution Channel
11.3.2.9 Spain
11.3.2.9.1 Spain Smart Inhalers Market by Product
11.3.2.9.2 Spain Smart Inhalers Market by Indication
11.3.2.9.3 Spain Smart Inhalers Market by Distribution Channel
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands Smart Inhalers Market by Product
11.3.2.10.2 Netherlands Smart Inhalers Market by Indication
11.3.2.10.3 Netherlands Smart Inhalers Market by Distribution Channel
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland Smart Inhalers Market by Product
11.3.2.11.2 Switzerland Smart Inhalers Market by Indication
11.3.2.11.3 Switzerland Smart Inhalers Market by Distribution Channel
11.3.2.1.12 Austria
11.3.2.12.1 Austria Smart Inhalers Market by Product
11.3.2.12.2 Austria Smart Inhalers Market by Indication
11.3.2.12.3 Austria Smart Inhalers Market by Distribution Channel
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe Smart Inhalers Market by Product
11.3.2.13.2 Rest of Western Europe Smart Inhalers Market by Indication
11.3.2.13.3 Rest of Western Europe Smart Inhalers Market by Distribution Channel
11.4 Asia-Pacific
11.4.1 Asia-Pacific Smart Inhalers Market by Country
11.4.2 Asia-Pacific Smart Inhalers Market by Product
11.4.3 Asia-Pacific Smart Inhalers Market by Indication
11.4.4 Asia-Pacific Smart Inhalers Market by Distribution Channel
11.4.5 China
11.4.5.1 China Smart Inhalers Market by Product
11.4.5.2 China Smart Inhalers Market by Distribution Channel
11.4.5.3 China Smart Inhalers Market by Indication
11.4.6 India
11.4.6.1 India Smart Inhalers Market by Product
11.4.6.2 India Smart Inhalers Market by Indication
11.4.6.3 India Smart Inhalers Market by Distribution Channel
11.4.7 japan
11.4.7.1 Japan Smart Inhalers Market by Product
11.4.7.2 Japan Smart Inhalers Market by Indication
11.4.7.3 Japan Smart Inhalers Market by Distribution Channel
11.4.8 South Korea
11.4.8.1 South Korea Smart Inhalers Market by Product
11.4.8.2 South Korea Smart Inhalers Market by Indication
11.4.8.3 South Korea Smart Inhalers Market by Distribution Channel
11.4.9 Vietnam
11.4.9.1 Vietnam Smart Inhalers Market by Product
11.4.9.2 Vietnam Smart Inhalers Market by Indication
11.4.9.3 Vietnam Smart Inhalers Market by Distribution Channel
11.4.10 Singapore
11.4.10.1 Singapore Smart Inhalers Market by Product
11.4.10.2 Singapore Smart Inhalers Market by Indication
11.4.10.3 Singapore Smart Inhalers Market by Distribution Channel
11.4.11 Australia
11.4.11.1 Australia Smart Inhalers Market by Product
11.4.11.2 Australia Smart Inhalers Market by Indication
11.4.11.3 Australia Smart Inhalers Market by Distribution Channel
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Smart Inhalers Market by Product
11.4.12.2 Rest of Asia-Pacific Smart Inhalers Market by Indication
11.4.12.3 Rest of Asia-Pacific Smart Inhalers Market by Distribution Channel
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Smart Inhalers Market by Country
11.5.1.2 Middle East Smart Inhalers Market by Product
11.5.1.3 Middle East Smart Inhalers Market by Indication
11.5.1.4 Middle East Smart Inhalers Market by Distribution Channel
11.5.1.5 UAE
11.5.1.5.1 UAE Smart Inhalers Market by Product
11.5.1.5.2 UAE Smart Inhalers Market by Indication
11.5.1.5.3 UAE Smart Inhalers Market by Distribution Channel
11.5.1.6 Egypt
11.5.1.6.1 Egypt Smart Inhalers Market by Product
11.5.1.6.2 Egypt Smart Inhalers Market by Indication
11.5.1.6.3 Egypt Smart Inhalers Market by Distribution Channel
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Smart Inhalers Market by Product
11.5.1.7.2 Saudi Arabia Smart Inhalers Market by Indication
11.5.1.7.3 Saudi Arabia Smart Inhalers Market by Distribution Channel
11.5.1.8 Qatar
11.5.1.8.1 Qatar Smart Inhalers Market by Product
11.5.1.8.2 Qatar Smart Inhalers Market by Indication
11.5.1.8.3 Qatar Smart Inhalers Market by Distribution Channel
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Smart Inhalers Market by Product
11.5.1.9.2 Rest of Middle East Smart Inhalers Market by Indication
11.5.1.9.3 Rest of Middle East Smart Inhalers Market by Distribution Channel
11.5.2 Africa
11.5.2.1 Africa Smart Inhalers Market by Country
11.5.2.2 Africa Smart Inhalers Market by Product
11.5.2.3 Africa Smart Inhalers Market by Indication
11.5.2.4 Africa Smart Inhalers Market by Distribution Channel
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Smart Inhalers Market by Product
11.5.2.5.2 Nigeria Smart Inhalers Market by Indication
11.5.2.5.3 Nigeria Smart Inhalers Market by Distribution Channel
11.5.2.6 South Africa
11.5.2.6.1 South Africa Smart Inhalers Market by Product
11.5.2.6.2 South Africa Smart Inhalers Market by Indication
11.5.2.6.3 South Africa Smart Inhalers Market by Distribution Channel
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Smart Inhalers Market by Product
11.5.2.7.2 Rest of Africa Smart Inhalers Market by Indication
11.5.2.7.3 Rest of Africa Smart Inhalers Market by Distribution Channel
11.6 Latin America
11.6.1 Latin America Smart Inhalers Market by Country
11.6.2 Latin America Smart Inhalers Market by Product
11.6.3 Latin America Smart Inhalers Market by Indication
11.6.4 Latin America Smart Inhalers Market by Distribution Channel
11.6.5 Brazil
11.6.5.1 Brazil America Smart Inhalers Market by Product
11.6.5.2 Brazil America Smart Inhalers Market by Indication
11.6.5.3 Brazil America Smart Inhalers Market by Distribution Channel
11.6.6 Argentina
11.6.6.1 Argentina America Smart Inhalers Market by Product
11.6.6.2 Argentina America Smart Inhalers Market by Indication
11.6.6.3 Argentina America Smart Inhalers Market by Distribution Channel
11.6.7 Colombia
11.6.7.1 Colombia America Smart Inhalers Market by Product
11.6.7.2 Colombia America Smart Inhalers Market by Indication
11.6.7.3 Colombia America Smart Inhalers Market by Distribution Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Smart Inhalers Market by Product
11.6.8.2 Rest of Latin America Smart Inhalers Market by Indication
11.6.8.3 Rest of Latin America Smart Inhalers Market by Distribution Channel
12. Company Profile
12.1 Pneuma Respiratory Inc
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 H&T Presspart Manufacturing Ltd
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 COHERO Health Inc
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Personal Air Quality Systems Private Limited
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Adherium Limited
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Cognita Labs
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Teva Pharmaceuticals Industries Ltd
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Amiko Digital Health Limited
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Novartis AG
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Propeller Health
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Biobanking Market size was valued at USD 76.68 billion in 2023, and is expected to reach USD 151.11 billion by 2031 and grow at a CAGR of 8.85% over the forecast period 2024-2031.
The Clinical Trial Imaging Market Size was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.14 billion by 2031 and grow at a CAGR of 7.5% over the forecast period 2024-2031.
The Dentures Market was valued USD 1.62 Billion in 2023 and estimated to reach USD 3.00 Billion by 2032 at compound annual growth rate 7.10% during the forecast period 2024-2032.
The Metagenomics Market size was estimated at USD 2.02 billion in 2023 and is expected to reach USD 6.32 billion by 2032 with a growing CAGR of 13.53% during the forecast period of 2024-2032.
The Autism Spectrum Disorder Treatment Market size was valued at USD 2.16 Billion in 2023 and is expected to reach USD 3.71 Billion By 2032 and grow at a CAGR of 6.2% over the forecast period of 2024-2032.
The Global Vaccine Market Size valued at USD 74.7 billion in 2023, projected to reach USD 186.5 billion by 2032, with a CAGR of 10.7%.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
